about
Adjuvant chemotherapy for resected early-stage non-small cell lung cancerSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseasePooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.Cyclooxygenase 2 inhibitors and cancer chemopreventionSignificance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.Gemcitabine and pemetrexed (Alimta) in thoracic cancers: present and future perspectives. Introduction and current controversies.Epothilones: a new generation of microtubule-stabilizing compounds.Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.Combined modality treatment of lung cancer (NSCLC and SCLC).Chemotherapy for non-small-cell lung cancer. Part 2: Advanced disease.Ongoing and future trials of biologic therapies in lung cancer.The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer.Phase II study of imatinib in patients with small cell lung cancer.Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.Non-small cell lung cancer: the challenges of the next decadeA simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancerAdjuvant treatment of lung cancer: current status and potential applications of new regimens.Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.Adjuvant chemotherapy in completely resected non-small-cell lung cancer.Adjuvant chemotherapy in early-stage non-small cell lung cancer.Cutaneous side-effects of kinase inhibitors and blocking antibodies.Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors.Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutationAdjuvant or induction cisplatin-based chemotherapy for operable lung cancer.A catalyst for change: the European cancer Patient's Bill of Rights.Non-small-cell lung cancer.PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.Is sacrifying the phrenic nerve during thymoma resection worthwhile?Tirapazamine with cisplatin and vinorelbine in patients with advanced non-small-cell lung cancer: a phase I/II study.Imatinib in small cell lung cancer.Autologous tracheal replacement for cancer.Subclavian artery resection and reconstruction for thoracic inlet neoplasms.The Sino-French 2012 Conference in Thoracic Oncology: an international academic platform for in-depth exchange on comprehensive research.Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience.
P50
Q24187439-3F550D33-C1E5-4437-917F-81D80C791E0FQ24200518-A79D9A9C-F7A7-4354-A486-417AC4FFC494Q24243664-BD43C84C-A723-45A3-BB76-A05216250DFEQ27313799-C16145B3-1F94-480F-BD50-92A5E022FE72Q27853349-A3DBB74F-D4E5-483A-AFAD-0DE0EE1FD5F7Q28175624-8CB35F21-637C-4006-B4CC-DF564BA4EFEFQ30358684-476C96C9-3B8F-4FEF-96B9-B0DFA82630E3Q30580553-DD1AB746-9B9E-4B41-8E71-3819B24FC756Q34564091-72EE43F3-7FF4-4BAF-A6CD-EA92A12CB3A7Q34718267-31DB80A6-F28B-499A-8AEF-D6178EBAC49EQ34988754-53846E40-D70F-43AB-8C93-50F8C79573EAQ35093359-0C6B01CC-FB34-4993-A7B7-19B1AC745190Q35110477-93CC2BDB-61B0-4C85-8D4A-772CEDFC0054Q35123034-A532B5A4-4FEC-4C89-8AFA-3B5E3104BFF6Q35179468-E9079505-77D0-4558-AF3B-BF0844484140Q35208910-CED3066B-7AF4-482F-879E-FB389E92DA27Q35607926-D8313CD5-F3FE-4459-BED1-CEAB2B834687Q35959859-6FFACCBA-80E3-47C6-954B-E81836901E06Q35971331-3DFC191B-D7E1-4794-BEDF-C41256DFC152Q35987286-8AA83294-7469-4531-98EA-952CABC19465Q36033439-46F56B07-2B81-4DA9-8C27-9AAE7C5518CAQ36110382-2D9C0423-9B33-43E7-907D-E32781EF5A58Q36123348-E1E89343-B5BD-4457-841D-5BFDC03A66F8Q36179370-3656AB79-9BB6-4040-9E78-2C4FB3CB9204Q36181698-0F435A79-370A-4A40-BDB3-64D4A1E96490Q36487093-959D595B-AA3C-4E87-B187-3D46356E4C58Q36821101-3413D524-6CF0-41AB-A0D5-2A268CF54FEAQ36915205-35E78DF3-51A0-4C1A-8A1F-7A4D882DF52BQ36985910-2C766D90-9C84-4579-A95B-32FAF9D64C40Q37526881-71DB47F8-59F3-400A-AD6C-91FE71BF0978Q37644553-46BC67BA-A4FC-4114-81D3-DDC0E352BA9BQ37874768-2FBEC058-5F26-4569-A8FC-98BEB0B2A0C3Q39194354-CE23D4D9-DEE3-4A3B-94B4-C3143C42A698Q40173286-95F6898F-944F-4DA4-8126-A44767353744Q40510197-D4A33A3F-75FF-47D4-82B6-094CA3AC6917Q40574323-B71F425A-785C-4771-B04B-F279780AC8D6Q40845542-7E1D891B-7A11-4AF7-B4AD-66CF9059C7DAQ40845547-F52B082F-6B42-4E0A-B2A6-AFB05E043C06Q42857519-6381C743-C494-4BC8-A763-6A865A272564Q43045505-D0DA14C4-B82B-4FFC-956E-060FE381390A
P50
description
Médecin cancérologue
@fr
name
Thierry Le Chevalier
@ast
Thierry Le Chevalier
@de
Thierry Le Chevalier
@en
Thierry Le Chevalier
@es
Thierry Le Chevalier
@fr
Thierry Le Chevalier
@it
type
label
Thierry Le Chevalier
@ast
Thierry Le Chevalier
@de
Thierry Le Chevalier
@en
Thierry Le Chevalier
@es
Thierry Le Chevalier
@fr
Thierry Le Chevalier
@it
prefLabel
Thierry Le Chevalier
@ast
Thierry Le Chevalier
@de
Thierry Le Chevalier
@en
Thierry Le Chevalier
@es
Thierry Le Chevalier
@fr
Thierry Le Chevalier
@it
P21
P31
P4124
thierry-le-chevalier_67348
P569
1948-08-12T00:00:00Z